NGL Fine-Chem Limited has informed the Exchange about change in Management
NGLFINE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 10.8 pts more than Nifty Microcap 250 and 11.0 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
NGL Fine-Chem Limited held its Board Meeting on May 21, 2026 and approved the audited financial results for Q4 and full year ended March 31, 2026. Consolidated revenue grew 36% to Rs 50,095.47 lakhs from Rs 36,825.67 lakhs in the prior year, with profit after tax more than doubling to Rs 4,812.67 lakhs. The Board recommended a final dividend of Rs 1.75 per share (35% on face value of Rs 5). The 45th AGM is scheduled for August 25, 2026 with record date August 18, 2026. The company also re-appointed Mr. Rajesh Lawande as Whole-Time Director and Mrs. Sarala Menon as Independent Director for 5-year terms each, subject to shareholder approval. New internal auditors and cost auditors were appointed for FY 2026-27.
Strong financial performance with near-doubling of profits is positive for shareholders. The re-appointment of Mr. Rajesh Lawande, who is related to Mrs. Ajita Nachane (sister), raises a governance flag as this represents a promoter family entry on the board.